Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MT-4561 |
| Synonyms | |
| Therapy Description |
MT-4561 is a BRD4 degrader, which decreases downstream signaling and may inhibit tumor growth (Eur J Cancer (2024), Vol 211, Supp 1, 114607). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MT-4561 | MT4561|MT 4561 | BRD4 Inhibitor 11 | MT-4561 is a BRD4 degrader, which decreases downstream signaling and may inhibit tumor growth (Eur J Cancer (2024), Vol 211, Supp 1, 114607). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06943521 | Phase Ib/II | MT-4561 | A Study of MT-4561 in Patients With Various Advanced Solid Tumors | Recruiting | USA | 1 |